Work

Use of dexrazoxane as a cardioprotectant in patients receiving doxorubicin or epirubicin chemotherapy for the treatment of cancer. The Provincial Systemic Treatment Disease Site Group.

Year: 1999

Type: article

Source: PubMed

Authors: L Seymour, V Bramwell, L A Moran

Language: English

Topic: Chemotherapy-induced cardiotoxicity and mitigation

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W82259717

FWCI: 0.718

Cites:

Cited by: 78

Related to: 10